oral bisphosphonates (Fosamax, etc) might decrease the risk of breast cancer

January 2010

Women are hearing that oral bisphosphonates (Fosamax, etc) might decrease the risk of breast cancer.

A new look at the Women's Health Initiative suggests one-third fewer breast cancers in postmenopausal women taking oral bisphosphonates.

Another observational study from Israel shows a similar benefit.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cardiology The Zetia controversy and New Year's resolutions will spark new emphasis on treating lipids
Gastroenterology Ondansetron is being used more for acute nausea and vomiting
Migraine Sumavel DosePro, a new NEEDLE-FREE sumatriptan injection for migraines
Women's Health oral bisphosphonates (Fosamax, etc) might decrease the risk of breast cancer
Women's Health more emphasis on avoiding valproate during pregnancy
Cardiology whether warfarin is beneficial for MODERATE-risk patients with atrial fibrillation
Respiratory & Allergy whether saline nasal irrigation or "neti pots" increase sinus infections
Psychiatry increasing use of atypical antipsychotics in children
Supplements high-dose folic acid supplements might INCREASE cancer risk
Supplements ensuring kids get enough vitamin D
Obesity & Weight Loss people will be trying various products to try to lose weight
Interactions a specific list of drugs to avoid with Plavix
Cardiology using IV iron to improve heart failure symptoms